STOCK TITAN

[SCHEDULE 13G] Replimune Group, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/31/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/31/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/31/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

Replimune Group

NASDAQ:REPL

REPL Rankings

REPL Latest News

REPL Latest SEC Filings

REPL Stock Data

644.07M
79.89M
2%
104.95%
23.79%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
WOBURN